Lobbying client · LD-2 disclosures
Reata Pharmaceuticals
Texas
6 filings from 2 registrants · 2012–2013 · latest filed Aug 1, 2013
Reported on its behalf
$105K
every LD-2 on file
Its own filed spend
$65K
lobbying for itself
Fees to outside firms
$40K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
3 filings
$105K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Who did the lobbying
Every lobbyist named on this client's filings.
- Yardly Pollas-Kimble Upstream ConsultingCovered position: DepChiefofStaff/LegDirector, Cong Bobby Rush3 filingsthrough 2012
- John M. Haddow Upstream ConsultingCovered position: Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal3 filingsthrough 2012
- Michael Eging Reata Pharmaceuticals2 filingsthrough 2012
- Mcclain C Haddow Upstream Consulting1 filingthrough 2012
Covered positions · 2 of 4 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: reata-pharmaceuticals.